Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients

<p>Abstract</p> <p>Background</p> <p>Current standard therapy commonly followed for chronic Hepatitis C Virus (HCV) in Pakistan is interferon alpha plus ribavirin combination therapy (IFN α/ribavirin) and pegylated interferon plus ribavirin (PegIFN/ribavirin). PegIFN/ribavirin has increased rate of...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Saleem Sana, Liaqat Ali, Rehman Irshad-ur, Afzal Samia, Butt Sadia, Hussain Abrar, Zafar Shamail, Idrees Muhammad, Akram Madiha, Ali Muhammad, Butt Azeem
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2011-05-01
Serija:	Virology Journal
Online dostop:	http://www.virologyj.com/content/8/1/234
Oznake:	Označite Brez oznak, prvi označite!